Pharma Alert Q&A: Viread China’s First Victim of Compulsory Licensing?

Innovative pharmaceuticals take notice. Reuters’ Tan Ee Lyn asserts that China “overhauled parts of its intellectual property laws” to allow generics companies to start exploiting patented medicines cheaply. In other words allowing compulsory licensing. Tan mentioned one medicine for HIV patients as a possible candidate for compulsory licensing.

 

 

China is known to be looking at Gilead Sciences Inc’s tenofovir, which is recommended by the World Health Organisation as part of a first-line cocktail treatment for AIDS patients, two
continue reading…

Parasitizing Trademarks of Drugs in China Breeds Resistant Malaria Parasite

World Health Organisation (WHO) officials say that counterfeit drugs and poor storage are endangering the health of millions of people in Asia. Ron Corben wrote for Voice Of Amercia the article WTO Fears Growing Malaria Drug Resistance May Be Spreading (November 28, 2010): “In recent years, authorities cracked down against illegal factories in China. Meanwhile […]

How to Protect Traditional Chinese Medicine?

Recently I have been corresponding about Traditional Chinese Medicine (TCM) and which intellectual property rights (IPR) can protect them. I just read Mr or Ms Jia’s interesting paper on TCM (Jia Q., The World Health Organization, ‘Traditional Chinese Medicine Could Make “Health for One” [Come] True’, 2006) which includes a very interesting chapter on intellectual […]

Origin Fake Malaria Medicine Traced By Scientific Effort

Every year about 500 million people become ill of malaria. Every year 1 million people die, because of one version of malaria called Plasmodium falciparum. One major problem is that not all malaria medicines are genuine and some have only a low dose of the active ingredient, so that the malaria parasite becomes resistent. Jeremy […]